FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2589307157> ?p ?o ?g. }

• W2589307157 endingPage "60" @default.
• W2589307157 startingPage "49" @default.
• W2589307157 abstract "Negative regulation of Toll-like receptor-4 (TLR4) is anticipated to control the pathogen-induced exaggerated immune response. However, effective TLR4 antagonists with scarce off-target effects are yet to be developed. To fill this void, we sought to design small peptide-inhibitors of the TLR4/MD2-LPS interaction. Here we report novel TLR4-antagonistic peptides (TAP), identified through phage display, endowed with the LPS-induced proinflammation inhibition, and confirmed in mice. TAPs-attributed TLR4-antagonism were initially evaluated through NF-κB inhibition in HEK-blue hTLR4 and RAW264.7 cells, and further reinforced by the downregulation of MAPKs (mitogen-activated protein kinases), NF-κB, interleukin 6, and suppression of the oxidative-stress products and iNOS in macrophages and human peripheral blood mononuclear cells (hPBMCs). Among these, TAP2 specifically halted the TLR4, but not other TLRs signaling, which was further confirmed by the biophysical kinetic assay. Finally, TAP2 diminished LPS-elicited systemic cytokine response in vivo, suggesting that TAPs, specifically TAP2, have the potential to treat TLR4-mediated immune ailments." @default.
• W2589307157 created "2017-03-03" @default.
• W2589307157 creator A5014656376 @default.
• W2589307157 creator A5020674417 @default.
• W2589307157 creator A5034150631 @default.
• W2589307157 creator A5036635642 @default.
• W2589307157 creator A5037767272 @default.
• W2589307157 creator A5053830220 @default.
• W2589307157 creator A5059912723 @default.
• W2589307157 creator A5070919578 @default.
• W2589307157 creator A5073434176 @default.
• W2589307157 creator A5083971971 @default.
• W2589307157 date "2017-05-01" @default.
• W2589307157 modified "2023-10-16" @default.
• W2589307157 title "TLR4/MD2 specific peptides stalled in vivo LPS-induced immune exacerbation" @default.
• W2589307157 cites W1441835895 @default.
• W2589307157 cites W1507805168 @default.
• W2589307157 cites W1561771836 @default.
• W2589307157 cites W1586581625 @default.
• W2589307157 cites W1777927172 @default.
• W2589307157 cites W1906664533 @default.
• W2589307157 cites W1963802005 @default.
• W2589307157 cites W1975459052 @default.
• W2589307157 cites W1975840650 @default.
• W2589307157 cites W1977039417 @default.
• W2589307157 cites W1979096813 @default.
• W2589307157 cites W1985031521 @default.
• W2589307157 cites W1985477675 @default.
• W2589307157 cites W1986611577 @default.
• W2589307157 cites W1988338695 @default.
• W2589307157 cites W1988795126 @default.
• W2589307157 cites W1995586746 @default.
• W2589307157 cites W2000141520 @default.
• W2589307157 cites W2004465286 @default.
• W2589307157 cites W2004998163 @default.
• W2589307157 cites W2013469022 @default.
• W2589307157 cites W2014067910 @default.
• W2589307157 cites W2020117714 @default.
• W2589307157 cites W2028658694 @default.
• W2589307157 cites W2034028219 @default.
• W2589307157 cites W2034222489 @default.
• W2589307157 cites W2043202073 @default.
• W2589307157 cites W2044573804 @default.
• W2589307157 cites W2062487226 @default.
• W2589307157 cites W2070360032 @default.
• W2589307157 cites W2075426423 @default.
• W2589307157 cites W2078771755 @default.
• W2589307157 cites W2086676026 @default.
• W2589307157 cites W2086959309 @default.
• W2589307157 cites W2087867048 @default.
• W2589307157 cites W2087906216 @default.
• W2589307157 cites W2090163159 @default.
• W2589307157 cites W2094476373 @default.
• W2589307157 cites W2095833996 @default.
• W2589307157 cites W2101363646 @default.
• W2589307157 cites W2108017786 @default.
• W2589307157 cites W2112309507 @default.
• W2589307157 cites W2119693712 @default.
• W2589307157 cites W2120211786 @default.
• W2589307157 cites W2121597792 @default.
• W2589307157 cites W2122132244 @default.
• W2589307157 cites W2127265964 @default.
• W2589307157 cites W2127934565 @default.
• W2589307157 cites W2130655121 @default.
• W2589307157 cites W2138842022 @default.
• W2589307157 cites W2144679012 @default.
• W2589307157 cites W2145221987 @default.
• W2589307157 cites W2145881473 @default.
• W2589307157 cites W2154761807 @default.
• W2589307157 cites W2155201844 @default.
• W2589307157 cites W2156613610 @default.
• W2589307157 cites W2157339124 @default.
• W2589307157 cites W2158591358 @default.
• W2589307157 cites W2162826697 @default.
• W2589307157 cites W2175687390 @default.
• W2589307157 cites W2257036949 @default.
• W2589307157 cites W2281788915 @default.
• W2589307157 cites W2346299902 @default.
• W2589307157 cites W2404096427 @default.
• W2589307157 cites W2520613901 @default.
• W2589307157 cites W2528441696 @default.
• W2589307157 cites W4246356731 @default.
• W2589307157 doi "https://doi.org/10.1016/j.biomaterials.2017.02.023" @default.
• W2589307157 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28254693" @default.
• W2589307157 hasPublicationYear "2017" @default.
• W2589307157 type Work @default.
• W2589307157 sameAs 2589307157 @default.
• W2589307157 citedByCount "36" @default.
• W2589307157 countsByYear W25893071572017 @default.
• W2589307157 countsByYear W25893071572018 @default.
• W2589307157 countsByYear W25893071572019 @default.
• W2589307157 countsByYear W25893071572020 @default.
• W2589307157 countsByYear W25893071572021 @default.
• W2589307157 countsByYear W25893071572022 @default.
• W2589307157 countsByYear W25893071572023 @default.
• W2589307157 crossrefType "journal-article" @default.
• W2589307157 hasAuthorship W2589307157A5014656376 @default.
• W2589307157 hasAuthorship W2589307157A5020674417 @default.

• next